Boda Guo

613 total citations · 1 hit paper
17 papers, 482 citations indexed

About

Boda Guo is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Boda Guo has authored 17 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in Boda Guo's work include Sexual function and dysfunction studies (4 papers), Renal cell carcinoma treatment (3 papers) and Hormonal and reproductive studies (3 papers). Boda Guo is often cited by papers focused on Sexual function and dysfunction studies (4 papers), Renal cell carcinoma treatment (3 papers) and Hormonal and reproductive studies (3 papers). Boda Guo collaborates with scholars based in China, Italy and Taiwan. Boda Guo's co-authors include Feiya Yang, Nianzeng Xing, Wenkuan Wang, Qinxin Zhao, Mingshuai Wang, Lu Yin, Sujun Han, Dong Chen, Haihua Xiao and Lingpu Zhang and has published in prestigious journals such as Advanced Materials, Advanced Science and Urology.

In The Last Decade

Boda Guo

17 papers receiving 479 citations

Hit Papers

Cuproptosis Induced by ROS Responsive Nanoparticles with ... 2023 2026 2024 2025 2023 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boda Guo China 9 190 151 109 96 78 17 482
Tuanwei Sun United States 8 237 1.2× 161 1.1× 331 3.0× 63 0.7× 62 0.8× 9 675
Wenjie Feng China 14 172 0.9× 220 1.5× 102 0.9× 101 1.1× 71 0.9× 30 646
Li Tu China 14 171 0.9× 218 1.4× 78 0.7× 60 0.6× 97 1.2× 27 580
Chunfang Wei China 8 278 1.5× 161 1.1× 207 1.9× 39 0.4× 134 1.7× 10 554
Minxia Zhu China 9 238 1.3× 149 1.0× 114 1.0× 101 1.1× 115 1.5× 13 483
Liru Xue China 15 222 1.2× 180 1.2× 152 1.4× 77 0.8× 48 0.6× 26 735
Santhosh Kalash Rajendrakumar South Korea 12 224 1.2× 110 0.7× 80 0.7× 43 0.4× 87 1.1× 16 364
Yuting Xiang China 10 165 0.9× 111 0.7× 91 0.8× 31 0.3× 56 0.7× 16 403
Yuquan Wang China 7 145 0.8× 162 1.1× 121 1.1× 92 1.0× 95 1.2× 9 561
Mercedes Salido Spain 14 145 0.8× 114 0.8× 30 0.3× 37 0.4× 65 0.8× 22 403

Countries citing papers authored by Boda Guo

Since Specialization
Citations

This map shows the geographic impact of Boda Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boda Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boda Guo more than expected).

Fields of papers citing papers by Boda Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boda Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boda Guo. The network helps show where Boda Guo may publish in the future.

Co-authorship network of co-authors of Boda Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Boda Guo. A scholar is included among the top collaborators of Boda Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boda Guo. Boda Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhao, Qinxin, Ganghao Liang, Boda Guo, et al.. (2023). Polyphotosensitizer‐Based Nanoparticles with Michael Addition Acceptors Inhibiting GST Activity and Cisplatin Deactivation for Enhanced Chemotherapy and Photodynamic Immunotherapy. Advanced Science. 10(13). e2300175–e2300175. 29 indexed citations
2.
Guo, Boda, Feiya Yang, Lingpu Zhang, et al.. (2023). Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy. Advanced Materials. 35(22). e2212267–e2212267. 286 indexed citations breakdown →
3.
4.
Guo, Boda, et al.. (2023). Ursolic acid alleviates chronic prostatitis via regulating NLRP3 inflammasome‐mediated Caspase‐1/GSDMD pyroptosis pathway. Phytotherapy Research. 38(1). 82–97. 13 indexed citations
5.
Wang, Hai, et al.. (2021). Vardenafil in the Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis. Advances in Therapy. 38(2). 1301–1313. 3 indexed citations
6.
Guo, Boda, et al.. (2020). The role of cytoreductive nephrectomy in renal cell carcinoma patients with liver metastasis. Bosnian Journal of Basic Medical Sciences. 21(2). 229–234. 6 indexed citations
8.
Guo, Boda & Ming Liu. (2020). A survival predicting model for patients with papillary renal cell carcinoma. Translational Andrology and Urology. 9(5). 2313–2314. 1 indexed citations
9.
Gao, Ming, Xiang Liu, Jianhua Sun, et al.. (2020). Abnormal degree centrality in lifelong premature ejaculation patients: an fMRI study. Brain Imaging and Behavior. 15(3). 1412–1419. 17 indexed citations
10.
Guo, Boda & Ming Liu. (2020). Surgery in renal cell carcinoma patients with lung and bronchus metastasis. Annals of Translational Medicine. 8(6). 405–405. 1 indexed citations
11.
Wang, Miao, Boda Guo, Huimin Hou, et al.. (2020). The impact of atrial fibrillation on outcomes in patients undergoing radical prostatectomy. World Journal of Urology. 39(5). 1509–1519. 6 indexed citations
12.
Gao, Ming, Boda Guo, Jianhua Sun, et al.. (2020). Striatum-related Intrinsic Connectivity Deficits in Lifelong Premature Ejaculation Patients. Urology. 143. 159–164. 10 indexed citations
14.
Wang, Hai, et al.. (2020). miR-4270 regulates cell proliferation and apoptosis in patients with Sertoli cell-only syndrome by targeting GADD45A and inactivating the NOTCH signaling pathway.. PubMed. 12(9). 5730–5740. 11 indexed citations
15.
Zhang, Ji‐Wei, et al.. (2019). [Effect and safety of the Chinese medicine Qianlieshutong Capsules in the treatment of benign prostatic hyperplasia: A meta-analysis].. PubMed. 25(11). 1021–1030. 1 indexed citations
16.
Sun, Xinghuai, Xu Ji, Yi-Cong Zheng, & Boda Guo. (1994). Primary chronic angle-closure glaucoma in Chinese--a clinical exploration of its pathogenesis and natural course.. PubMed. 10(3). 176–85. 8 indexed citations
17.
Guo, Boda, et al.. (1984). Steroid-induced ocular hypertension in high myopia.. PubMed. 97(1). 24–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026